http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014067959-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f73dac012733ce8c3dbda5177dc07f71 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-177 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-70535 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-735 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17 |
| filingDate | 2013-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_35c8fd5b47c53ac6c2e94c230dc373f6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_96c4adda74bd1525a3c6713e3a642f4d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ccf853ec4266400281dddddd74c9b05d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7bdd798de6c2087465082e07ad142657 |
| publicationDate | 2014-05-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2014067959-A1 |
| titleOfInvention | A pharmaceutical composition for use in treating or preventing either one or both of an inflammatory disease and an autoimmune disease |
| abstract | The present invention relates to a pharmaceutical composition for use in treating or preventing either one or both of an inflammatory disease and an autoimmune disease, wherein the pharmaceutical composition comprises soluble Fcγ receptor (FcγR) as active ingredient; and wherein the pharmaceutical composition is designed for administering a first dose of a therapeutically effective amount of soluble FcγR, followed by a safety period of several weeks, followed by a subsequent treatment cycle of at least two further administrations, wherein said therapeutically effective amount is effective to treat or prevent said disease in said patient. Further the invention relates to a pharmaceutical composition in the form of a multiple-dosage-kit which contains sufficient amounts of administration doses of soluble FcγR for effectively treating or preventing inflammatory diseases and/or autoimmune diseases in a patient. |
| priorityDate | 2012-10-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 57.